Skip to content

Clinical trials

Phase 2 Ovarian Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 2 Country / region: Italy Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20032
20041
20051
20064
20071
20083
20091
20102
20112
20135
20142
20151
20171
20184
20195
20203
20216
20225
20233
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Recruiting10
Unknown status8
Active, not recruiting5
Terminated2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute, Naples6
Hoffmann-La Roche4
AGC Biologics S.p.A.3
AstraZeneca3
Bayer3
Catholic University of the Sacred Heart3
Mario Negri Institute for Pharmacological Research3
Merck Sharp & Dohme LLC3
Corcept Therapeutics2
Eli Lilly and Company2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms60
Fallopian Tube Neoplasms13
Endometrial Neoplasms6
Breast Neoplasms5
Colorectal Neoplasms5
Pancreatic Neoplasms5
Stomach Neoplasms5
Biliary Tract Neoplasms4
Carcinoma, Non-Small-Cell Lung4
Urinary Bladder Neoplasms4

Trials

Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.